Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease
2017 · Pediatric Nephrology · 26 citations
https://doi.org/10.1007/s00467-017-3584-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Kazeem Olalekan is an academic researcher.
ORCID: 0000-0001-7666-7117Click to start Chat